富蘭克林坦伯頓全球投資系列-生技領航基金美元F(acc)股
9.80美元0.03(0.31%)
2022/07/04更新
績效 / 1月6.27%
3月12.23%
1年30.97%
晨星評等-
- 1.現金5.49%
- 2.股票8.57%
- 3.債券0.00%
- 4.其他85.94%
- 1.美國85.83%
- 2.英國4.38%
- 3.新興亞洲2.45%
- 4.歐洲不包含歐元區0.65%
- 5.加拿大0.56%
- 1.Vertex Pharmaceuticals Inc8.53%
- 2.Amgen Inc8.36%
- 3.Regeneron Pharmaceuticals Inc6.16%
- 4.Horizon Therapeutics PLC5.61%
- 5.Jazz Pharmaceuticals PLC5.14%
- 6.Gilead Sciences Inc4.95%
- 7.AstraZeneca PLC ADR4.19%
- 8.Illumina Inc3.69%
- 9.Biogen Inc3.19%
- 10.Seagen Inc Ordinary Shares3.06%
- 1.現金5.49%
- 2.股票8.57%
- 3.債券0.00%
- 4.其他85.94%
- 1.美國85.83%
- 2.英國4.38%
- 3.新興亞洲2.45%
- 4.歐洲不包含歐元區0.65%
- 5.加拿大0.56%
- 1.Vertex Pharmaceuticals Inc8.53%
- 2.Amgen Inc8.36%
- 3.Regeneron Pharmaceuticals Inc6.16%
- 4.Horizon Therapeutics PLC5.61%
- 5.Jazz Pharmaceuticals PLC5.14%
- 6.Gilead Sciences Inc4.95%
- 7.AstraZeneca PLC ADR4.19%
- 8.Illumina Inc3.69%
- 9.Biogen Inc3.19%
- 10.Seagen Inc Ordinary Shares3.06%